Recent observations with β-adrenoceptor blockade: Beneficial effects in hypertension and heart failure

American Journal of Hypertension

Volumn 11, Issue 1 II S, 1998, Pages

  Ruffolo Jr , Robert R ^a   Feuerstein, Giora Z ^a   Ohlstein, Eliot H ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

blockers; Carvedilol; Congestive heart failure; Hypertension

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIOXIDANT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; FREE RADICAL; INTERCELLULAR ADHESION MOLECULE 1; NORADRENALIN; TRANSCRIPTION FACTOR;

APOPTOSIS; ARTERIAL PRESSURE; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; HEART MUSCLE; HUMAN; HYPERTENSION; PRIORITY JOURNAL;

ADRENERGIC BETA-ANTAGONISTS; ANTIOXIDANTS; CARBAZOLES; HEART; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; HUMANS; HYPERTENSION; PROPANOLAMINES;

EID: 0345310066     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(97)00423-8     Document Type: Conference Paper

References (29)

1. Feuerstein GZ, Ruffolo RR. Carvedilol, a novel multiple action antihypertensive agent with antioxidant activity and the potential for myocardial and vascular protection. Eur Heart J. 16:(suppl F):1995;38-42.
2. Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med. 334:1996;1349-1397.
3. Nichols AJ, Gellai M, Ruffolo RR Jr. Studies on the mechanism of arterial vasodilation produced the novel antihypertensive agent, carvedilol. Fundam Clin Pharmacol. 5:1991;25-38.
4. Ruffolo RR, Boyle DA, Brooks DP, et al. Carvedilol a novel cardiovascular drug with multiple actions . Cardiovasc Drug Rev. 10:1992;127-157.
5. Ruffolo RR Jr, Gellai M, Hieble JP, Willette RN, Nichols AJ. The pharmacology of carvedilol. Eur J Clin Pharmacol. 38:1990;S82-S88.
6. Dupont AG, Vander Niepan P, Tallymamsy Y, et al. Effect of carvedilol on ambulatory blood pressure by renal hemodynamics, and cardiac function in essential hypertension. J Cardiovasc Pharmacol. 10:(suppl 11):1987;S130-S136.
7. Dupont AG. Effects of carvedilol on renal function. Eur J Clin Pharmacol. 38:(suppl 2):1990;S96-S100.
8. Gellai M, DeWolf R, Ruffolo RR Jr. Effect of carvedilol on renal hemodynamics and renal excretory function in spontaneously hypertensive rats. Pharmacology. 41:1990;200-206.
9. Yue TL, Liu T, Feuerstein GZ. Carvedilol, a new vasodilator and β-adrenoceptor antagonist, inhibits oxygen-radical-mediated lipid peroxidation in swine ventricular membranes. Pharmacol Commun. 1:1992;27-35.
10. Yue TL, Cheng HY, Lysko PG, et al. Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger. J Pharmacol Exp Ther. 263:1992;92-98.
11. McPhillips JJ, Schwemer GT, Scott DI, et al. Effects of carvedilol on blood pressure in patients with mild to moderate hypertension. Drugs. 36:(suppl 6):1988;82-91.
12. Yue TL, McKenna PJ, Lysko PG, et al. SB 211475, a metabolite of carvedilol, a novel antihypertensive agent, is a potent antioxidant. Eur J Pharmacol. 251:1994;237-243.
13. Feuerstein R, Yue TL. A potent antioxidant, SB 209995, inhibits oxygen-radical-mediated lipid peroxidation and cytotoxicity. Pharmacology. 48:1994;385-391.
14. Bril A, Slivjak M, DiMartino J, et al. Cardioprotective effects of carvedilol, a novel β-adrenoceptor antagonist with vasodilating properties, in anaesthetized minipigs comparison with propranolol . Cardiovasc Res. 26:1992;518-525.
15. Brunvand H, Kvitting PM, Rynning SE, Grong K. Carvedilol protects against lethal reperfusion injury through antiadrenergic mechanisms. J Cardiovasc Pharmacol. 28:1996;409-417.
16. Feuerstein GZ, Hamburger SA, Smith EF, et al. Myocardial protection with carvedilol. J Cardiovasc Pharmacol. 19:(suppl 1):1992;S138-S141.
17. Hamburger SA, Barone FC, Feuerstein GZ, Ruffolo RR Jr. Carvedilol (Kredex) reduces infarct size in a canine model of acute myocardial infarction. Pharmacology. 43:1991;113-120.
18. Ma XL, Yue TL, Lopez BL, et al. Carvedilol, a new β-adrenoceptor blocker and free radical scavenger, attenuates myocardial ischemia-reperfusion injury in hypercholesterolemic rabbits. J Pharmacol Exp Ther. 277:1996;128-136.
19. Engler RL, Dahlgren MD, Morris D, et al. Role of leukocytes in the response to acute myocardial ischemia and reflow in dogs. Am J Physiol. 251:1986;H314-H323.
20. Go LO, Murray CE, Richard VJ, et al. Myocardial neutrophil accumulation during reperfusion after reversible or irreversible ischemic injury. Am J Physiol. 255:1988;H1188-H1198.
21. Smith EF, Griswold DE, Egan JW, et al. Reduction of myocardial damage and polymorphonuclear leukocyte accumulation following coronary artery occlusion and reperfusion by the thromboxane receptor antagonist BM13.505. J Cardiovasc Pharmacol. 13:1989;715-722.
22. Yue TL, Wang X, Gu JL, et al. Carvedilol, a new vasodilating beta-adrenoceptor blocker, inhibits oxidation of low density lipoproteins by vascular smooth muscle cells and prevents leukocyte adhesion to smooth muscle cells. J Pharmacol Exp Ther. 273:1995;1442-1449.
23. Kerr JFR, Wyllie AH, Currie AR. Apoptosis a basic biological phenomenon with wide-ranging implications in tissue kinetics . Br J Cancer. 26:1972;239-257.
24. Wyllie AH, Kerr JF, Currie AR. Cell death the significance of apoptosis . Int Rev Cytol. 687:1980;251-306.
25. Liu Y, Kitsis RN. Induction of DNA synthesis and apoptosis in cardiac myocytes by E1A oncoprotein. J Cell Biol. 133:1996;325-334.
26. Kajstura J, Cheng W, Reiss K, et al. Apoptotic and necrotic myocyte cell death are independent contributing variables of infarct size in rats. Lab Invest. 74:1996;86-107.
27. Gottlieb RA, Burleson KO, Kloner RA, et al. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest. 94:1994;1621-1628.
28. Tanaka M, Ito H, Adachi S, et al. Hypoxia induces apoptosis with enhanced expression of FAS antigen messenger RNA in cultured neonatal rat cardiomyocytes. Circ Res. 75:1994;426-433.
29. Hockenbery DM, Oltvai ZN, Yin YM, et al. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell. 75:1993;241-251.